BMJ study warns UK-US pharma trade deal could cause 229,000 excess NHS deaths
By
Edna Mohamed
Summary
Research published in the British Medical Journal (BMJ) warns that a UK-US pharmaceutical trade deal signed in December could cause an estimated 229,000 excess deaths. The deal requires the UK to increase NHS spending on new US medicines, diverting billions of pounds away from other critical areas of Britain's National Health Service. The analysis highlights the potential human cost of trade agreements that prioritize pharmaceutical industry interests over public health spending.
Source
bskyBMJ study warns UK-US pharma trade deal could cause 229,000 excess NHS deathsaje.newsKey quotes
· 3 pulledResearch published in the British Medical Journal (BMJ) has found that a United Kingdom-United States pharmaceutical deal could cause 229,000 excess deaths as a result of the diversion of billions of pounds away from Britain's National Health Service (NHS).
In December, the UK and US signed a pharmaceutical trade deal, under which the US government agreed not to impose tariffs on UK pharmaceutical and medical technology exports for the next three years.
In return, the British government committed to increasing NHS spending on new US medicines from 0.
You might also wanna read
Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o
bmj.com·5d agoAnalysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o
bmj.com·5d ago
UK-US pharmaceuticals deal will divert £45bn from essential NHS services, says doctors' union
Burnham urged to ditch ‘dangerous’ UK-US NHS drug deal
Critics question consent, clinical utility, and industry influence in UK's Our Future Health programme
The BMJ investigates concerns about the UK's Our Future Health (OFH) programme, the country's largest ever health research initiative with 1
bmj.com·12d ago
NHS trusts fail to account for over £400m in medical student training funds, BMJ investigation finds
An investigation by The BMJ reveals that NHS trusts in England have failed to account for over £400 million (nearly a quarter) of the £1.7 b
bmj.com·14d ago
Conflicts of interest threaten integrity of GLP-1 therapy guidance, experts warn
This article discusses the risks of conflicts of interest in clinical guidance for GLP-1 receptor agonists (like Ozempic, Wegovy) used for o
bit.ly·18d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.